arrow
S

Sylvain Lother

University of Manitoba
H指数:24
被引数:4,595

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Antianaerobic Antibiotics With Mortality and the Gut Microbiome: A Substudy of the BALANCE Randomized Clinical Trial

抗厌氧菌抗生素与死亡率和肠道微生物组的关联:BALANCE随机临床试验的子研究

2026-08-040
OAAI
Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial

COVID-19重症患者中的中剂量肝素血栓预防:一项随机临床试验

2026-07-012
OAAI
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial

识别血流感染中抗生素疗程的治疗效应异质性:BALANCE随机临床试验的探索性事后分析

2025-05-010
PRE
Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists

老年人骨髓增生异常综合征和急性髓性白血病的支持治疗策略: 加拿大血液学家的全国调查

2024-11-200
PRE
The association of antiplatelet agents with mortality among patients with non-COVID-19 community-acquired pneumonia: a systematic review and meta-analysis
2024-07-010
OAAI
Surgical Triage and Timing for Patients With Coronavirus Disease: A Guidance Statement from The Society of Thoracic Surgeons
2022-08-013
OAAI
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 A Randomized Trial
2020-10-20380
OAAI
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
2020-08-06963
OAAI
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial
2020-05-0716
OAAI
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)

综述: 羟氯喹和氯喹治疗SARS-CoV-2 (新型冠状病毒肺炎)

2020-04-15135
OAAI